SPONSOR
Intergroupe Francophone de Cancerologie Thoracique
Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 3, Phase 2
Intergroupe Francophone de Cancerologie Thoracique is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Metastatic NSCLC, Stage III NSCLC.
The trial portfolio spans Phase 2, Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Intergroupe Francophone de Cancerologie Thoracique
How many clinical trials has Intergroupe Francophone de Cancerologie Thoracique sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Intergroupe Francophone de Cancerologie Thoracique, of which 2 are actively recruiting participants. These trials cover conditions including Metastatic NSCLC, Stage III NSCLC. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Intergroupe Francophone de Cancerologie Thoracique research focus on?
Intergroupe Francophone de Cancerologie Thoracique clinical trials span Metastatic NSCLC, Stage III NSCLC. The research pipeline includes Phase 2, Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Intergroupe Francophone de Cancerologie Thoracique clinical trial?
To participate in a Intergroupe Francophone de Cancerologie Thoracique trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Intergroupe Francophone de Cancerologie Thoracique trials with current recruitment status updated daily.
Clinical Trials by Intergroupe Francophone de Cancerologie Thoracique
NCT05255302 Phase 2, Phase 3
Recruiting
De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction
Metastatic NSCLC
NCT06656598 Phase 2
Recruiting
Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer
Stage III NSCLC
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology